Table 2.
The enriched pathways of significantly down-regulated DEGs
| Pathway | Count | p-value | Adjusted p-value |
|---|---|---|---|
| Biosynthesis of phenylpropanoids | 18 | 8.60E-14 | 1.20E-11 |
| Phenylpropanoid biosynthesis | 13 | 2.20E-12 | 1.50E-10 |
| Biosynthesis of plant hormones | 19 | 4.90E-12 | 2.30E-10 |
| Methane metabolism | 12 | 2.80E-11 | 9.60E-10 |
| Phenylalanine metabolism | 11 | 2.40E-10 | 6.70E-09 |
| Biosynthesis of terpenoids and steroids | 13 | 3.60E-09 | 8.30E-08 |
| Steroid biosynthesis | 7 | 2.60E-08 | 5.10E-07 |
| Biosynthesis of alkaloids derived from terpenoid and polyketide | 8 | 4.90E-05 | 8.50E-04 |
| Amino sugar and nucleotide sugar metabolism | 7 | 5.10E-05 | 7.80E-04 |
| Starch and sucrose metabolism | 6 | 2.10E-04 | 2.90E-03 |
| Glycolysis/Gluconeogenesis | 6 | 3.00E-04 | 3.70E-03 |
| Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid | 7 | 4.60E-04 | 5.30E-03 |
| Pyruvate metabolism | 5 | 6.00E-04 | 6.40E-03 |
| Biosynthesis of alkaloids derived from shikimate pathway | 7 | 6.40E-04 | 6.30E-03 |
| Cysteine and methionine metabolism | 5 | 1.00E-03 | 9.60E-03 |